Effect of an aldose reductase inhibitor on abnormalities of electroretinogram and vascular factors in diabetic rats

European Journal of Pharmacology

Volumn 326, Issue 1, 1997, Pages 45-51

  Hotta, Nigishi ^a   Koh, Naoki ^a   Sakakibara, Fumihiko ^a   Nakamura, Jiro ^a   Hara, Tomohiro ^a   Hamada, Yoji ^a   Fukasawa, Hideo ^a   Kakuta, Hironobu ^a   Sakamoto, Nobuo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

2,3 Diphosphoglycerate; Aldose reductase inhibitor; Diabetic retinopathy; Electroretinogram; Platelet aggregation; Sorbitol

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ALDOSE REDUCTASE INHIBITOR; FRUCTOSE; SORBITOL;

ANIMAL MODEL; ARTICLE; B WAVE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ELECTRORETINOGRAM; ERYTHROCYTE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OSCILLATORY POTENTIAL; PRIORITY JOURNAL; RAT; RETINA; STREPTOZOCIN DIABETES; THROMBOCYTE AGGREGATION;

2,3-DIPHOSPHOGLYCERATE; ALDEHYDE REDUCTASE; ANIMALS; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; DIPHOSPHOGLYCERIC ACIDS; ELECTRORETINOGRAPHY; ENZYME INHIBITORS; INSULIN; LIPIDS; MALE; PLATELET AGGREGATION; RATS; RATS, WISTAR; RETINA; TETRAZOLES; THIOPHENES;

EID: 0030974784     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00135-0     Document Type: Article

References (31)

1. Alberti, K.G.M.M., Darley, J.H., Emerson, P.M., Hockaday, T.D.R., 1972. 2,3-Diphosphoglycerate and tissue oxygenation in uncontrolled diabetes mellitus. Lancet ii, 391.
2. Algver, P., 1968. Clinical studies on the oscillatory potentials of the human electroretinogram with special reference to the scotopic b-wave. Acta Ophthalmol. 46, 993.
3. Ardlie, N.G., Packham, M.A., Mustard, J.F., 1970. Adenosine diphosphate-induced platelet aggregation in suspension of washed rabbit platelets. Br. J. Haematol. 19, 7.
4. Belfiore, F., 1980. Enzyme Regulation and Metabolic Diseases. Karger, Basel.
5. Ernest, J.T., Goldstick, T.K., Engerman, R.L., 1983. Hyperglycemia impairs retinal oxygen autoregulation in normal and diabetic dogs. Invest. Ophthalmol. Vis. Sci. 24, 985.
6. Ernst, E., Matrai, A., 1986. Altered red and white blood cell rheology in type 2 diabetes. Diabetes 35, 1412.
7. Hara, T., Nakamura, J., Koh, N., Sakakibara, F., Hamada, Y., Sasaki, H., Naruse, K., Nakashima, E., Takeuchi, N., Inukai, S., Hotta, N., 1995. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy. J. Lab. Clin. Med. 126, 541.
8. Hotta, N., Kakuta, H., Fukasawa, H., Kimura, M., Koh, N., Iida, M., Terashima, H., Morimura, T., Sakamoto, N., 1985. Effect of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats. Diabetologia 28, 176.
9. Hotta, N., Kakuta, H., Fukasawa, H., Koh, N., Matsumae, H., Kimura, M., Sakamoto, N., 1988. Prevention of diabetic retinopathy by an aldose reductase inhibitor in fructose-fed streptozotocin-diabetic rats. In: Sakamoto, N., Kinoshita, J.H., Kador, P.F., Hotta, N. (Eds.), Polyol Pathway and Its Role in Diabetic Complications. Elsevier, Amsterdam, p. 311.
10. Hotta, N., Sakamoto, N., Fukuda, M., Matsui, M., Ando, F., 1990. Epalrestat can truly prevent diabetic retinopathy in clinical double-blind study. Diabetes 39 (Suppl.), 61A.
11. Hotta, N., Kakuta, H., Fukasawa, H., Koh, N., Sakakibara, F., Komori, T., Sakamoto, N., 1992. Effect of niceritrol on streptozotocin-induced diabetic neuropathy in rats. Diabetes 41, 587.
12. Hotta, N., Kakuta, H., Fukasawa, H., Koh, N., Sakakibara, F., Nakamura, J., Hamada, Y., Wakao, T., Hara, T., Mori, K., Naruse, K., Nakashima, E., Inukai, S., Sakamoto, N., 1995a. Effect of a potent new aldose reductase inhibitor, TAT, on diabetic neuropathy in rats. Diabetes Res. Clin. Pract. 27, 107.
13. Hotta, N., Nakamura, J., Kakuta, H., Fukasawa, H., Koh, N., Sakakibara, F., Mori, K., Sakamoto, N., 1995b. Niceritrol prevents the decrease in red blood cell 2,3-diphosphoglycerate and neuropathy in streptozotocin-induced diabetic rats. J. Diabetes Complications 9, 133.
14. Kador, P.F., Akagi, Y., Takahashi, Y., Ikeda, H., Wyman, N., Kinoshita, J.H., 1990. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Arch. Ophthalmol. 108, 1301.
15. Kohner, E.M., 1993. Diabetic retinopathy. Br. Med. J. 307, 1195.
16. Kozak, W.M., Deneault, L.G., Rogowska, J., 1983. ERG amplitude and latency changes during early diabetes mellitus in rats. Doc. Ophthalmol. Proc. Ser. 37, 351.
17. Little, N.L., 1981. Alterations in blood elements in the pathogenesis of diabetic retinopathy. Ophthalmology 88, 647.
18. Lowe, G.D.O., Ghafour, I.M., Belch, J.J.F., Forbes, C.D., Fould, W.S., Maciush, A.C., 1986. Increased blood viscosity in diabetic proliferative retinopathy. Diabetes Res. 3, 67.
19. Lowitt, S., Malone, J.I., Salem, A.I., Kozak, W.M., Orfalian, Z., 1993. Acetyl-L-carnitine corrects electroretinographic deficits in experimental diabetes. Diabetes 42, 1115.
20. Miller, R.F., Dowling, J.E., 1970. Intracellular responses of the Müller (glial) cells of mudpuppy retina: their relation to the b-wave of the electroretinogram. J. Neurophysiol. 33, 323.
21. Mizuno, K., Kato, N., Matsubara, A., Nakano, K., Kurono, M., 1992. Effects of a new aldose reductase inhibitor, (2S,4S:)-6-fluoro 2′,5′-dioxospiro [chroman-4,4′-imidazolidinine]-2-carboxamide (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats. Metabolism 41, 1081.
22. + hypothesis. J. Neurophysiol. 51, 164.
23. O'Malley, B.C., Ward, J.D., Timperley, W.R., Portor, N.R., Preston, F.E., 1975. Platelet abnormalities in diabetic peripheral neuropathy. Lancet ii, 1274.
24. Robey, C., Dasmahapatra, A., Cohen, M.P., Suarez, S., 1987. Sorbinil partially prevents decreased erythrocyte deformability in experimental diabetes mellitus. Diabetes 36, 1010.
25. Robison, W.G. Jr., Kador, P.F., Kinoshita, J.H., 1983. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor. Science 221, 1177.
26. Segawa, M., Hirata, Y., Fujimori, S., Okada, Y., 1988. The development of electroretinogram abnormalities and the possible role of polyol pathway activity in diabetic hyperglycemia and galactosemia. Metabolism 37, 454.
27. Simonsen, S.E., 1968. ERG in diabetics. In: Francois, J. (Ed.), The Clinical Value of Electroretinography. Karger, Basel, p. 403.
28. Speros, P., Price, J., 1981. Oscillatory potential. History, techniques and potential use in the evaluation of disturbances of retinal circulation. Survey Ophthalmol. 25, 237.
29. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J. Clin. Invest. 94, 853.
30. Takiguchi, Y., Wada, K., Nakashima, M., 1992. Effect of aldose reductase inhibitor on the inhibition of platelet aggregation induced by diabetic rat plasma. Eur. J. Pharmacol. 251, 289.
31. Yonemura, D., Aoki, T., Tsuzuki, K., 1962. Electroretinogram in diabetic retinopathy. Arch. Ophthalmol. 68, 49.